The latest clinical report from Prime, The evolution of GLP-1s, delves into some of the latest insights, empowering health plans, pharmacies and members with recent research, data, trends and forecasting for these medications, which are approved to treat type 2 diabetes, obesity and cardiovascular conditions
Sexual function changes that are primarily neurochemical, meaning dopamine or serotonin mediated, typically resolve within one to two months of discontinuation as the brain reward system recalibrates
The peptide component might provide additional anti-ageing benefit, but only with realistic expectations, consistent long-term use, and understanding that results wont approach what injectable treatments deliver
These weight loss shots increase your insulin production and triggers a hormone that keeps food in your stomach longer
When selecting a telehealth provider for GLP-1 medications, consider these factors: Klarity Health stands out by providing consistent care with the same provider throughout your treatment journey
However, the recent FDA approvals of Wegovy (2021) and Zebound (2023) for weight loss have been met with a tremendous increase in demand for these drugs